APA (7th ed.) Citation

R, G., N, S., Á, A., M, P., F, D., T, M., . . . A, S. (2022). An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program. Epilepsia open, 7(4), 578. https://doi.org/10.1002/epi4.12624

Chicago Style (17th ed.) Citation

R, Guerrini, et al. "An Examination of the Efficacy and Safety of Fenfluramine in Adults, Children, and Adolescents with Dravet Syndrome in a Real-world Practice Setting: A Report from the Fenfluramine European Early Access Program." Epilepsia Open 7, no. 4 (2022): 578. https://doi.org/10.1002/epi4.12624.

MLA (9th ed.) Citation

R, Guerrini, et al. "An Examination of the Efficacy and Safety of Fenfluramine in Adults, Children, and Adolescents with Dravet Syndrome in a Real-world Practice Setting: A Report from the Fenfluramine European Early Access Program." Epilepsia Open, vol. 7, no. 4, 2022, p. 578, https://doi.org/10.1002/epi4.12624.

Warning: These citations may not always be 100% accurate.